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Abstract
Introduction
Employers may incur costs related to absenteeism among employ-
ees who have chronic diseases or unhealthy behaviors. We ex-
amined the association between employee absenteeism and 5 con-
ditions: 3 risk factors (smoking, physical inactivity, and obesity)
and 2 chronic diseases (hypertension and diabetes).
Methods
We  identified  5  chronic  diseases  or  risk  factors  from  2  data
sources: MarketScan Health Risk Assessment and the Medical Ex-
penditure Panel Survey (MEPS). Absenteeism was measured as
the number of workdays missed because of sickness or injury. We
used zero-inflated Poisson regression to estimate excess absentee-
ism as the difference in the number of days missed from work by
those who reported having a risk factor or chronic disease and
those who did not. Covariates included demographics (eg, age,
education, sex) and employment variables (eg, industry, union
membership). We quantified absenteeism costs in 2011 and adjus-
ted them to reflect growth in employment costs to 2015 dollars.
Finally, we estimated absenteeism costs for a hypothetical small
employer  (100 employees)  and a  hypothetical  large  employer
(1,000 employees).
Results
Absenteeism estimates ranged from 1 to 2 days per individual per
year depending on the risk factor or chronic disease. Except for
the physical inactivity and obesity estimates, disease- and risk-
factor–specific estimates were similar in MEPS and MarketScan.
Absenteeism increased with the number of risk factors or diseases
reported. Nationally, each risk factor or disease was associated
with annual absenteeism costs greater than $2 billion. Absentee-
ism costs ranged from $16 to $81 (small employer) and $17 to
$286 (large employer) per employee per year.
Conclusion
Absenteeism costs associated with chronic diseases and health risk
factors  can  be  substantial.  Employers  may  incur  these  costs
through  lower  productivity,  and  employees  could  incur  costs
through lower wages.
Introduction
Since the 1980s, the prevalence of chronic diseases and unhealthy
lifestyle behaviors among American adults has increased. For in-
stance, in 1980, the prevalence of hypertension was 24% and dia-
betes prevalence was below 3%; however, by 2012 the prevalence
of hypertension was 29% and diabetes 9% (1–3). In the US work-
ing population, one-third of adults are obese (4,5), approximately
1 in 5 is a smoker (6), and more than half do not meet physical
activity recommendations (4,7). The Centers for Disease Control
and Prevention recognizes obesity, tobacco use, and physical in-
activity as “winnable battles.” Winnable battles are public health
priorities for which effective evidence-based interventions exist
and could be broadly implemented to bring about large reductions
in illness and death.
Employers are interested in reducing rates of chronic disease and
reducing health risk factors because employers bear about 58% of
total employee medical costs (8). Compared with their counter-
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parts, employees who have chronic diseases and unhealthy life-
style behaviors have higher medical costs, miss more workdays,
and are potentially less productive at work (9–12). The increasing
age of the labor force may increase the prevalence of these condi-
tions and their associated costs (13). In light of these considera-
tions,  many employers  have adopted workplace wellness  pro-
grams to improve health-related behaviors and reduce the incid-
ence of chronic conditions (14).
Numerous studies have quantified the effect of diseases and risk
factors on absenteeism (9–12,15–17). These studies often focused
on a single condition and used various data sets, samples, and time
periods, making it difficult to estimate the benefits of policies that
affect  multiple conditions simultaneously.  Among studies that
analyzed multiple conditions, some did not separately estimate ab-
senteeism or account for other employee characteristics that may
confound the relationship between chronic conditions and missed
workdays.
The objective of this study was to estimate the association between
absenteeism and 5 conditions: 3 risk factors (obesity, smoking,
physical inactivity) and 2 chronic diseases (hypertension and dia-
betes). We applied the same method and regression framework to
all conditions and analyzed absenteeism in 2 of the most com-
monly used data sources for health care costs — health risk ap-
praisals (HRAs) from a large privately insured claims database
(MarketScan) and a nationally representative health expenditure
survey (the Medical Expenditure Panel Survey [MEPS]).
Methods
We analyzed absenteeism from 2008 through 2011 using samples
of respondents who were aged 18 to 64 years, were continuously
enrolled in the databases and employed for at least 1 year, were
not pregnant, and responded to the question on missed workdays.
We analyzed data from the HRA subsample of the Truven Health
MarketScan database. MarketScan is one of the largest commer-
cial health care claims databases in the United States, representing
more than 50 million employees and their dependents; the data-
base is a de-identified convenience subpopulation of privately in-
sured individuals (18). The HRA is a voluntary 3%-to-5% sub-
sample of the MarketScan commercial claims data and contains
self-reported information on health status (eg, hypertension) and
health risk factors (eg, smoking). If a respondent completed more
than 1 HRA in any year, we used the most recent HRA submitted.
MEPS is a publicly available, de-identified, annual survey consist-
ing of a 2-year rolling panel design that collects data on the health
care use and health status of respondents (19). The MEPS sample
is representative of the civilian, noninstitutionalized US popula-
tion. Our study used variables that were self-reported by respond-
ents.
We measured absenteeism in MarketScan using responses to the
question, “In the past 6 months how many days have you missed
work due to illness or injury?” We annualized workdays missed
by multiplying responses by 2. In MEPS we measured absentee-
ism using responses to the question, “How many times [did you]
miss more than a half-day of work since the last interview?” We
annualized the missed workday variable by adjusting responses for
the length of time respondents met the inclusion criteria.
We classified MarketScan respondents as physically inactive if
they reported exercising fewer than 4 to 5 times per week with at
least 30 minutes of moderate activity per period of exercise (20).
We classified MEPS respondents as physically inactive if they re-
sponded no to the question asking if they “spend half an hour or
more in moderate or vigorous physical activity at least three times
a week.” We classified respondents as obese if their body mass in-
dex (BMI in kg/m2) was reported as 30 or higher. BMI was self-
reported in MEPS; we calculated BMI from self-reported height
and weight in MarketScan as ([weight in pounds × 703]/height in
inches2). We classified respondents as smokers if they responded
affirmatively to the question, “Do you currently smoke?” MEPS
respondents with diabetes and hypertension were identified ac-
cording to responses to questions that asked them if they had “ever
been told by a doctor or other health professional” that they had
the disease. For MarketScan, respondents also self-reported hyper-
tension or diabetes but did not distinguish between physician-dia-
gnosed and self-diagnosed disease.
We adjusted for age categories (18–34, 35–49, 50–64 y), sex, edu-
cational attainment (no high school degree or GED [general edu-
cational development], high school degree, some college or col-
lege degree,  or  graduate  degree),  region (Northeast,  Midwest,
South, and or West), industry (11 classifications [Box]), and em-
ployment (full-time or part-time). MEPS data allowed for addi-
tional control factors: union membership (yes, no, inapplicable),
race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic,
Asian),  occupation  code  of  the  employee  (14  classifications
[Box]), employer-paid sick leave (yes or no), and whether the re-
spondent had private insurance (yes or no). We used an indicator
for whether the respondent lived in a metropolitan statistical area
(MSA) as a summary statistic to compare data sources but did not
include MSA in regression analyses.
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Box. Industry Categories in MarketScan and Medical Expenditure Panel
Survey
MarketScan
Agriculture, forestry, fishing
Communications, utilities
Construction
Finance, insurance, real estate
Manufacturing, durable goods
Manufacturing, nondurable goods
Oil & gas extraction, mining
Retail trade
Services
Transportation
Wholesale
Medical Expenditure Panel Survey
Agriculture
Construction
Financial services
Fishing
Forestry
Manufacturing
Mining
Other services
Professional services
Real estate
Retail trade
Transportation
Utilities
Wholesale trade
Statistical analysis
We analyzed both data sets using Stata 12.1 and estimated a zero-
inflated Poisson regression model (21,22) where the dependent
variable was the number of self-reported workdays missed. The
zero-inflated Poisson model accounts for additional zeroes in the
dependent variable (missed workdays) by first fitting a logistic re-
gression to predict the likelihood of an excess zero and then fit-
ting a Poisson regression to obtain the count of missed workdays
for nonexcess zeroes. We used the same set of explanatory vari-
ables as controls for both stages of the regression analysis. To es-
timate excess absenteeism or excess missed workdays, we used
Stata’s margins command to provide the predicted difference in
missed workdays for those with and those without a risk factor or
chronic disease. For the MarketScan data, we controlled for re-
spondents who completed an HRA in more than 1 year with an in-
dicator. We also included year indicators, clustered by respondent,
and used robust standard errors in all regressions. All analyses us-
ing MEPS data were weighted to produce estimates of the civilian,
noninstitutionalized population meeting the sample inclusion cri-
teria. Standard errors were adjusted for the MEPS’s complex sur-
vey design.
We estimated 6 sets of regressions in 2 categories. First, we estim-
ated the effect of each risk factor and chronic disease separately
(smoking, obesity, physical inactivity, diabetes, and hypertension)
while adjusting for different levels of controls (none, basic demo-
graphic, and full model). In doing so, we observed how estimates
of absenteeism changed as we adjusted for additional factors. In
the regressions, we adjusted for demographic variables (eg, age
group, sex, and region), year of survey, work status indicators (eg,
union membership, full-time status), and industry indicators (eg,
industry type). In the second set of 3 regressions, we estimated
risk factors and chronic diseases separately (ie, risk factors only
and chronic diseases only). Finally, we estimated the association
between the number of conditions, risk factors, chronic diseases,
and total missed workdays.
To compute the base cost of absenteeism for the employed work-
force, we multiplied the estimated number of excess missed work-
days per year by daily compensation costs for an 8-hour workday.
We calculated compensation costs using the Bureau of Labor Stat-
istics average hourly compensation cost for US employers in 2011
($30.45)  (23).  We adjusted hourly  employee compensation to
2015 dollars using the employment cost index ($33.00) (24).
An employee’s absence may reduce the productivity of coworkers,
particularly when work relies on team production. To capture the
team-based spillover effect of a missed workday, we multiplied
absenteeism costs by 1.6 (11,15,25). In an alternate scenario and
to derive our lower-bound estimate on cost, we allowed for the
scenario where an employee was able to make up work, or when
work was completed by colleagues. In this scenario we multiplied
costs by 0.43 (26). Using these 2 scenarios, the lower- and upper-
bound range for the cost of a 1-hour absence would be $14.19 and
$52.81 (in 2015 dollars).
To obtain condition-specific absenteeism costs, we multiplied the
cost per person per year by the prevalence of the condition. When
computing national costs, we used the MEPS prevalence and ab-
senteeism estimates and multiplied them by the total employed
population in the United States in 2011: 139 million people (27).
To estimate costs for employers, we assumed a small employer
had 100 employees and a large employer had 1,000 employees.
Because MEPS is a nationally representative survey, we used the
MEPS data to extrapolate costs for small  employers.  We used
MarketScan estimates to extrapolate costs for large employers.
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MarketScan HRA and MEPS are de-identified data sets; our re-
search did not involve human subjects (defined by Title 45 Code
of Federal Regulations, Part 46). Therefore, approval from an in-
stitutional review board was not required.
Results
In MarketScan, 356,758 observations met our inclusion criteria
(Table 1). Of these, 127,143 individuals filled out an HRA in more
than 1 year; thus, the 356,758 observations came from 229,615 in-
dividuals. The prevalence rates of the 5 conditions studied in the
MarketScan sample were 27.4% for current smoking, 55.9% for
physical inactivity, 26.0% for obesity, 18.0% for hypertension,
and 4.8% for diabetes. In the MEPS analysis, 24,006 individuals
met inclusion criteria. The MEPS prevalence rates were 17.2% for
current smoking, 39.7% for physical inactivity, 30.0% for obesity,
24.9% for hypertension, and 6.0% for diabetes. The average num-
ber of missed workdays was 2.2 days per year for all employees in
the MarketScan sample and 2.8 days per year for all employees in
the MEPS sample. In MarketScan, 200,665 (56.2%) respondents
and in MEPS 12,498 (52.1%) respondents reported zero absentee-
ism days.
MEPS and MarketScan estimates of the number of regression-ad-
justed excess missed workdays in the full model were qualitat-
ively similar to each other, although the point estimates were dif-
ferent (Figure 1 and Table 2). MarketScan captures data on a more
homogenous and potentially more economically advantaged popu-
lation than does MEPS. Hence, it was not surprising that the res-
ults between the 2 data sets diverged slightly. However, as we ad-
justed for additional covariates the estimates for each data set be-
came closer to each other in magnitude. Differences between the 2
data sets remained for estimates of physical inactivity and obesity.
Figure 1. Regression-adjusted number of excess missed workdays per year by
chronic disease or risk factor from the full model, which controlled for industry
and employee characteristics. Error bars indicate 95% confidence intervals.
Abbreviation: MEPS, Medical Expenditure Panel Survey.
 
Individuals with a condition had significantly greater absenteeism
than those without one. For example, using MarketScan we estim-
ated that a smoker will miss 1.07 (95% confidence interval [CI],
0.83–1.31) more workdays than a nonsmoker. Across all condi-
tions, as we adjusted for additional covariates, the estimated mag-
nitude of excess missed workdays decreased (Table 2). When we
examined individuals with multiple risk factors or diseases, the ef-
fect of any 1 condition remained significant after we adjusted for
other factors. Similarly, adding risk factors and chronic diseases in
the same regression changed the magnitude of the coefficients, but
significance and coefficient sign remained the same.
We found a correlation between the number of conditions an em-
ployee reported and the predicted total number of missed work-
days per year (Figure 2). Employees with 0 or 1 condition missed
2.0 workdays (MarketScan) or 2.3 workdays (MEPS). Employees
with 2 or 3 conditions missed 4.5 days (MarketScan) or 3.7 days
(MEPS). Finally, individuals with 4 or 5 conditions missed 8.6
days (MarketScan) or 4.4 days (MEPS). We found a similar pat-
tern for number of risk factors or chronic diseases.
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Figure 2. Regression-adjusted number of missed workdays per year. Error bars
indicate 95% confidence intervals. Abbreviation: MEPS, Medical Expenditure
Panel Survey.
 
When we used our regression results to calculate the total cost of
absenteeism to employers, we found that obesity had the highest
total cost at $11.2 billion per year (Table 3). After obesity, total
costs for each condition were ranked as follows: hypertension
($10.3 billion), physical inactivity ($9.1 billion), current smoking
($3.6 billion), and diabetes ($2.2 billion). In our sensitivity ana-
lyses, lower and upper estimates for costs ranged between $0.9
billion (diabetes) and $17.9 billion (obesity).
Extrapolating these results to reflect employer size, we found that
per-year absenteeism for a small employer ranged from 6 days for
diabetes to 31 days for obesity and costs ranged from $1,621 for
diabetes to $8,065 for obesity (Table 4). A large employer (1,000
employees) could face absenteeism rates of 65 days for diabetes to
1,083 days for physically inactive employees. Annual costs for a
large employer could range from approximately $17,000 for dia-
betes to more than $285,000 for physical inactivity.
Discussion
We estimated that absenteeism costs associated with each of the 5
conditions — hypertension, diabetes, smoking, physical inactivity,
and obesity — were greater than $2 billion per condition per year.
Accounting for costs imposed by absenteeism will be useful in as-
sessing the impact of programs and policies that affect the preval-
ence of these conditions. We cannot determine from these data
whether employers bear this cost through lower profits or employ-
ees bear the cost through lower wages.
After adjusting for wage growth to 2015, our estimates of absent-
eeism costs were similar to previous estimates: for instance, for
obesity, our estimated cost of $11.2 billion (range, $4.8–$17.9 bil-
lion) was within the range of prior estimates: $4.3 billion in 2004
($5.5 billion in 2015 dollars) and $12.8 billion in 2008 ($14.6 bil-
lion in 2015 dollars) (10,28). Regarding the magnitude of excess
workdays missed, our estimate for smoking of about 1 day was
smaller than reported previously (2.3–2.6 days) (12,16). However,
when we added a control for former smokers, our MarketScan ab-
senteeism estimate increased to 2.2 days. (MEPS did not report
whether respondents were former smokers.)
Our absenteeism estimates for diabetes, 1 to 2 days, were smaller
than estimates  of  previous studies  (3  days)  (9).  Likewise,  our
physical inactivity estimates (1–2 days) were smaller than previ-
ous estimates (4 days) (17). Differences between our estimates and
prior estimates may be attributable to our more recent study peri-
od and our inclusion of additional controls, which tend to reduce
the number of missed workdays attributable to risk factors or dis-
eases.
Our study has several limitations. First, health-related conditions
(smoking, physical inactivity, obesity) are primary risk factors for
chronic diseases such as hypertension and diabetes. We did not
model the disease pathway or the potential interaction of health
risk factors and chronic diseases; prior research has the same limit-
ation. In addition, because we were not able to control for former
smokers in the MEPS sample, we underestimated the number of
missed workdays associated with smoking. Second, our employer-
specific estimates were extrapolations; we did not have actual em-
ployer size as a variable in the data set. Third, we did not account
for the relationship between the labor market (eg, employment and
wages) and disease status. One potential labor market outcome
could be that people with chronic conditions have lower-paying
jobs. However, recent research found no difference in wages after
controlling for health insurance costs (29). Fourth, our data did not
allow us to distinguish between type 1 and type 2 diabetes; never-
theless, most (>95%) Americans who report having diabetes have
type 2 diabetics, and our data probably reflects this proportion
(30). Fifth, the MarketScan data are not nationally representative;
however, MarketScan commercial encounters data in 2011 had
more than 52 million enrollees (employees and dependents) and
the database is projectable to 58% of the US population. The HRA
sample is a voluntary subset of employees, and respondents may
differ from the larger pool of MarketScan individuals in ways that
reduce the generalizability of results.
This is the first study to examine absenteeism associated with mul-
tiple  risk  factors  and  chronic  diseases  using  MarketScan  and
MEPS. We found the estimates of absenteeism to be similar for
the 2 data sets, except for physical inactivity and obesity.  The
substantial difference in physical inactivity estimates may reflect
differences between MarketScan and MEPS in how the question
on physical activity was worded. We find robust evidence that risk
factors  and  chronic  diseases  are  strongly  associated  with  in-
creased employee absenteeism.
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Workplace wellness programs have potential to reduce both med-
ical and absenteeism costs (31). Although such programs, their
comprehensiveness, and their potential returns vary, workplace
programs are important partners in improving health. As an ex-
ample, the American Heart Association reiterated in 2015 its com-
mitment to workplace wellness as a way of improving cardiovas-
cular health (14). While improving employee health and reducing
absenteeism initially benefit employers and employees, a healthy
workforce and an increase in productivity are national resources
with benefits that extend beyond private sector employers and
their employees.
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Tables
Table 1. Summary Statistics on US Workforce: Data From MarketScana and Medical Expenditure Panel Survey, 2008–2011b, c
Variable MarketScan (No. of Observations = 356,758
d) Medical Expenditure Panel Survey (N =24,006)
Self-reported workdays missed, n (SD) 2.2 (12.6) 2.8 (8.7)
Female 129,503 (36.3) 10,075 (42.0)
Age group, y
18–34 93,064 (26.1) 7,344 (30.6)
35–49 154,766 (43.4) 9,435 (39.3)
50–64 108,928 (30.5) 7,227 (30.1)
Current smokinge 60,477 (27.4) 4,122 (17.2)
Former smoking 12,126 (23.7) NA
Physical inactivitye 28,568 (55.9) 9,539 (39.7)
Obesity 92,910 (26.0) 7,190 (30.0)
Hypertensione 35,750 (18.0) 5,972 (24.9)
Diabetese 7,361 (4.8) 1,431 (6.0)
Educatione
No high school degree or GED 776 (0.4) 2,752 (11.5)
High school degree 11,740 (6.1) 10,229 (42.6)
Some college/college degree 178,120 (91.8) 5,654 (23.6)
Graduate degree 3,316 (1.7) 5,371 (22.4)
Metropolitan statistical area 341,029 (95.6) 20,470 (85.3)
Regionf
Northeast 104,504 (29.3) 4,308 (17.9)
Midwestg 38,541 (10.8) 5,368 (22.4)
South 118,979 (33.4) 8,954 (37.3)
West 94,563 (26.5) 5,376 (22.4)
Part-time employeeh 3,157 (0.9) NA
Employer offers paid sick leavei NA 15,753 (65.6)
Union membership 30,3 (8.5) 2,886 (12.0)
Private insurancei NA 20,389 (84.9)
Abbreviations: GED, general educational development; NA, not applicable.
a MarketScan is a large US commercial health care claims database; it is a de-identified convenience subpopulation of privately insured individuals (18).
b All values are number (percentage) unless otherwise indicated. Percentages may not total 100 because of rounding.
c All values are self-reported.
d The 356,758 observations were of 229,615 individuals.
e MarketScan denominators differed according to number of respondents to question.
f Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont. Midwest: Illinois, Indiana, Iowa,
Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South: Alabama, Arkansas, Delaware, District of Columbia,
Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas Virginia, and West Virginia. West: Alaska,
Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. 171 observations had missing values for re-
gions.
g MarketScan’s Midwest region is called “North Central.”
h The Medical Expenditure Panel Survey sample excluded part-time employees.
i MarketScan analysis did not identify those with paid sick leave; it used a sample of privately insured individuals.
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Table 2. Regression-Adjusted Estimates of the Effect of Selected Health Risk Factors or Chronic Diseases on Number of Excess Missed Workdaysa per Year per Em-
ployee in US Workforceb, c
Risk Factor or Disease
Single Factor or Diseased Multiple Factors or Diseasese
No Controls
Adjusted for Age,
Sex, Race Full Model Risk Factor Chronic Disease All
Medical Expenditure Panel Survey
Current smoking 0.67 (0.35–0.99) 0.76 (0.44–1.08) 0.58 (0.25–0.92) 0.66 (0.59–0.71) NA 0.26 (0.19–0.31)
Physical inactivity 0.73 (0.45–1.01) 0.64 (0.35–0.93) 0.63 (0.33–0.92) 0.49 (0.44–0.52) NA 0.50 (0.44–0.55)
Obesity 1.29 (0.98–1.60) 1.12 (0.79–1.44) 1.02 (0.70–1.33) 0.95 (0.90–1.00) NA 0.20 (0.17–0.26)
Hypertension 1.51 (1.21–1.82) 1.28 (0.97–1.58) 1.13 (0.84–1.42) NA 1.08 (1.03–1.12) 0.96 (0.90–1.00)
Diabetes 1.49 (1.09–1.88) 1.17 (0.77–1.57) 1.03 (0.63–1.42) NA 0.72 (0.63–0.80) 0.62 (0.53–0.70)
MarketScan
Current smoking 1.77 (1.64–1.90) 1.82 (1.69–1.97) 1.07 (0.83–1.31) 1.47 (0.07–2.2) NA 1.51 (0.77–2.25)
Current smoking, controlled
for former smoking
2.41 (1.66–3.16) 2.31 (1.57–3.05) 2.20 (1.45–2.95) 2.21 (1.76–2.66) NA 1.95 (1.23–2.74)
Physical inactivity 2.23 (1.80–2.67) 2.06 (1.64–2.49) 1.94 (1.51–2.36) 1.70 (1.26–2.13) NA 1.64 (1.20–2.08)
Obesity 0.92 (0.81–1.02) 0.75 (0.66–0.85) 0.59 (0.49–0.69) 1.16 (0.71–1.6) NA 0.88 (0.42–1.34)
Hypertension 2.38 (2.20–2.55) 2.06 (1.64–2.31) 1.23 (1.06–1.41) NA 0.73 (0.52–0.95) 0.85 (0.31–1.37)
Diabetes 2.29 (1.97–2.62) 2.05 (1.72–2.38) 1.35 (0.98–1.73) NA 1.17 (0.82–1.53) 1.71 (0.77–2.65)
Abbreviations: MEPS, Medical Expenditure Panel Survey; NA, not applicable.
a Number of excess missed workdays defined as the difference in the number of days missed from work by those who reported having a risk factor or chronic dis-
ease and those who did not.
b Data sources: MarketScan and Medical Expenditure Panel Survey [19], 2008–2011. MarketScan is a large US commercial health care claims database; it is a de-
identified convenience subpopulation of privately insured individuals (18).
c Regression estimates from zero-inflated Poisson regression, robust standard errors clustered by respondent (MarketScan). In addition, MEPS estimates weighted
and standard errors adjusted for complex survey design.
d Models for 1 risk factor or chronic disease in regression (specified by the row). The column depicts level of controls where the full model includes controls for age,
sex, race (MEPS only), industry, part-time status, union membership, region, and sick-leave policy (MEPS only).
e Models for multiple risk factors or diseases, listed by row (eg, risk factors regression includes smoking, inactivity, and obesity). All regressions include controls for
age, sex, race (MEPS only), industry, part-time status, union membership, region, and sick-leave policy (MEPS only).
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Table 3. Annual Cost of Absenteeism Borne by US Employers Because of Selected Health Risk Factors or Chronic Diseases Among Employeesa
Risk Factor or Disease
Prevalence, %b
No. of People in
US Workforce
With Condition, in
Millionsc
No. of Excess Missed
Workdaysd per
Employee per Yeare
Cost per Employee
per Year, $f
Total US Cost
per Year,
Billions, $g
US Cost Scenarioh,
Lower–Upper,
Billions, $
A B C D E F
Current smoking 17.0 23.6 0.58 153 3.6 1.6–5.9
Physical inactivity 39.7 55.2 0.63 166 9.1 3.9–14.6
Obesity 30.0 41.6 1.02 269 11.2 4.8–17.9
Hypertension 24.9 34.6 1.13 298 10.3 4.4–16.5
Diabetes 6.0 8.3 1.03 272 2.2 0.9–3.5
Abbreviation: MEPS, Medical Panel Expenditure Survey.
a Data sources: MarketScan and Medical Expenditure Panel Survey [19], 2008–2011. MarketScan is a large US commercial health care claims database; it is a de-
identified convenience subpopulation of privately insured individuals (18).
b Prevalence estimate from MEPS data (A).
c Assumes workforce population of 139 million people: B = A × 139 million.
d Number of excess missed workdays defined as the difference in the number of days missed from work by those who reported having a risk factor or chronic dis-
ease and those who did not.
e C = MEPS regression estimates for single factor or disease, full model (Table 2).
f Assumes an average employment cost of $33.00 per hour and an 8-hour work day (in 2015 dollars): D = C × 8 × 33.
g Total cost (E) = B × D in 2015 dollars.
h Lower and upper cost scenarios based on multipliers of 0.43 and 1.6 respectively: lower value = 0.43 × E; upper value = 1.6 × E.
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Table 4. Annual Total Absenteeism and Costs to Employers in the United States Because of Selected Health Risk Factors or Chronic Diseases Among Employees, by
Size of Employera
Condition Prevalence, %
No. of Excess
Missed Workdaysb
per Employee
Total No. of Missed
Workdays per Year
per Employer
Total Cost per
Year, $c
Cost per Employee per Year,
$c
Small firm (100 employees)d
Current smoking 17 0.58 10 2,603 26
Physical inactivity 40 0.63 25 6,603 66
Obesity 30 1.02 31 8,065 81
Hypertension 25 1.13 28 7,419 74
Diabetes 6 1.03 6 1,621 16
Large employer (1,000 employees)e
Current smoking 27 1.07 292 77,117 77
Physical inactivity 56 1.94 1,083 285,785 286
Obesity 26 0.59 153 40,498 40
Hypertension 18 1.23 221 58,450 58
Diabetes 5 1.35 65 17,107 17
a Data sources: MarketScan and Medical Expenditure Panel Survey (19), 2008–2011. MarketScan is a large US commercial health care claims database; it is a de-
identified convenience subpopulation of privately insured individuals (18).
b Number of excess missed workdays defined as the difference in the number of days missed from work by those who reported having a risk factor or chronic dis-
ease and those who did not.
c Based on average employment cost of $33.00 per hour and an 8-hour workday. All costs are in 2015 dollars.
d Small employer costs based on Medical Expenditure Panel Survey prevalence and estimated absenteeism.
e Large employer costs based on MarketScan prevalence and estimated absenteeism.
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